An Economic Analysis of Erlotinib, Docetaxel, Pemetrexed and Best Supportive Care as Second or Third Line Treatment of Non-Small Cell Lung Cancer

AuthID
 P-003-VCG
11
Author(s)
Parente, B
·
Sotto Mayor, R
·
Teixeira, E
·
Almodovar, T
·
Barata, F
·
Queiroga, H
·
Pereira, C
·
Pereira, H
·
Negreiro, F
·
Silva, C
Tipo de Documento
Article
Year published
2008
Publicado
in REVISTA PORTUGUESA DE PNEUMOLOGIA, ISSN: 0873-2159
Volume: 14, Número: 6, Páginas: 803-827 (25)
Indexing
Wos®
Pubmed®
Publication Identifiers
Pubmed: 19023496
Wos: WOS:000261705100006
Source Identifiers
ISSN: 0873-2159
Export Publication Metadata
Lista Marked
 Adicionar à lista Marked
Info
At this moment we don't have any links to full text documens.

Um espaço para investigadores e suas Instituições

Links Úteis

Ajuda

© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service